可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Roberts WL,Moulton L,Law TC,et al. Evaluation of nine auaomated highsensitivity Creactive protein methods:implication for clinical and epidemiological applications. Part2. [J]. Clin Chem,2001,47(3):418-425.
[2] Auer J,Berent R,Lassnig E,et al. Ccreative protein and coronary artery disease [J]. Jpn Heart J,2002,43(6):607-619.
[3] 胡大一,马长生. 心脏病学实践:规范化治疗[M]. 北京:人民卫生出版社,2004:233-245.
[4] Yamashita H,Shimada K,Seki E,et al. Concentrations of interleukins,interferon and creactive protein in stable and unstable angina pectoris [J]. Am J Cardiol,2003,91(2):133-136.
[5] Eriksson M,Egberg N,Wainala S,et al. Rerlationship between plasma fibrinogen and coronary heart disease in women[J]. Arterioscler Thromb Vasc Biol,1999,19(7):67-72.
[6] Biasucci LM,CDC,AHA. CDC/AHA Workshop on Mardwes of Inflammation and Cardiovascular disease: Application to Clinical and Public Health Practice. Clinical use of inflammatory markers in patients with cardiovascular disease :a background paper [J]. Circulation, 2004,110(25):e560-e567.
[7] Loukas M,Dabrowski M,Wagner T,et al. Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina immunohistochemical study [J]. Med Sci Monit,2002,8(4):BR144-BR148.
[8] Tousoulis D,Dawies G, Stefanadis T,et al. Inflammatory and thrombotic mechanisms in coronary atherosclerosis [J]. Heart, 2003,89(9):993-997.